Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mallinckrodt to buy Cadence Pharma for $1.3 bln
Yahoo/Reuters
Tuesday, February 11, 2014 - 9:22am
tags:
Mallinckrodt, Cadence Pharmaceuticals, M&A, Ofirmev
Yale Study On FDA Approvals -- Informative Or Irresponsible?
Forbes
Tuesday, February 11, 2014 - 9:08am
tags:
drug approvals, FDA
FDA requests 3 new studies on pill aimed at boosting female sex drive
Yahoo/AP
Tuesday, February 11, 2014 - 9:05am
tags:
FDA, female sexual dysfunction, flibanserin, Sprout Pharmaceuticals
The Red-Hot Biotech Sector Has Experts Screaming Bubble
Yahoo/Business Insider
Tuesday, February 11, 2014 - 9:04am
tags:
biotech
The Top 10 Reasons Why Drug, Device, Biologic, Research and Veterinary Facilities Fail FDA Inspections
Regulatory Focus
Tuesday, February 11, 2014 - 8:54am
tags:
devices, animal health, inspections, drug manufacturing
Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha
Tuesday, February 11, 2014 - 8:52am
tags:
Regeneron, Arcalyst, Eylea, Zaltrap
Actelion lifts profit view on strong start for new drug
Yahoo/Reuters
Tuesday, February 11, 2014 - 8:50am
tags:
Actelion, earnings, Opsumit
New Drug Shortages Decline in U.S. on Greater Scrutiny
Bloomberg
Monday, February 10, 2014 - 6:17pm
tags:
drug shortages
Should Teva take a breakup cue from Big Pharma?
Fierce Pharma
Monday, February 10, 2014 - 6:11pm
tags:
Teva Pharmaceuticals
Autistic Behavior Is Curbed in Animal Study of Older Drug
Bloomberg
Monday, February 10, 2014 - 6:07pm
tags:
Roche, autism, Bumex
Antibiotics developer Melinta lands a $70M round for PhIII development
Fierce Biotech
Monday, February 10, 2014 - 5:48pm
tags:
Melinta Therapeutics, antibiotics, delafloxacin
J&J team marks another setback on depression as midstage study flops
Fierce Biotech
Monday, February 10, 2014 - 5:46pm
tags:
JNJ, clinical depression, ADX71149, Addex, antidepressants
Government call for more HPV vaccination could boost GSK and Merck
Fierce Pharma
Monday, February 10, 2014 - 5:37pm
tags:
Merck, Gardasil, GSK, Cervarix, HPV, vaccines
Puma Biotech Surges on Favorable Patent Ruling
Yahoo/Zacks.com
Monday, February 10, 2014 - 5:32pm
tags:
Puma Biotechnology, patents, neratinib, Boehringer Ingelheim
Intercept Pharma rises as analyst raises her price and sales estimates for its liver drug OCA
Yahoo/AP
Monday, February 10, 2014 - 5:29pm
tags:
OCA, liver disease, Intercept Pharma
Gilead Sciences: Sovaldi Exclusion No Big Deal
Barron's
Monday, February 10, 2014 - 5:27pm
tags:
Sovaldi, Gilead Sciences, hepatitis C
Why AbbVie's First Year on Its Own Was a Success
Motley Fool
Monday, February 10, 2014 - 12:04pm
tags:
AbbVie
Arena and Eisai say agreement with CVS Caremark will expand access to weight loss drug Belviq
Yahoo/AP
Monday, February 10, 2014 - 12:03pm
tags:
Arena Pharmaceuticals, CVS Caremark, Belviq, Eisai
Merck joins race to copy Sanofi's diabetes drug Lantus
Yahoo/Reuters
Monday, February 10, 2014 - 12:02pm
tags:
Lantus, diabetes, Sanofi, Merck
Arena Reaches Critical Point On Insurance Coverage
Seeking Alpha
Monday, February 10, 2014 - 11:31am
tags:
Arena Pharmaceuticals, obesity, insurance, Belviq

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.